EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS2 holders
Total Value
$39.27M
Total Shares
1.76M
Net Share Change
+50.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$38.15M1.71M sharesUnchanged
